Home Blog Page 1712

From “Made in China” to “Intelligent Manufacturing”: Baida Popping Candy’s Global OEM/ODM Strategy Playbook

By
Advertorial Desk
-

CHAOZHOU, China, Dec. 12, 2025 /PRNewswire/ — As globalization continues to deepen,”Made in China” is gradually transforming into “Intelligent Manufacturing in China“. As a leading enterprise in the global popping candy sector, Baida Popping Candy (hereinafter referred to as “Baida”) is becoming a trusted partner for international food brands, relying on its excellent R&D strength, strict quality control systems, and highly flexible OEM/ODM service capabilities.

Recently, Baida officially released the “Baida Popping Candy OEM&ODM Strategy Handbook,” systematically showcasing its end-to-end capabilities—from product R&D and manufacturing to global supply chain services—providing one-stop customized solutions for customers in Europe and around the globe.


40 Years of Dedicated Development: Building a Global Leader in Popping Candy

Baida Popping Candy is one of the core brands under Guangdong Shantai Food Co., Ltd., established over forty years ago. Baida operates a 28,000-square-meter modern factory built to GMP standards, featuring 9 proprietary production lines and twenty high-speed automated packaging lines, enabling an annual capacity exceeding 10,000 tons of popping candy. The company has fully passed 15 international certifications, including ISO 22000, FDA, IFS, BRC, HALAL, and KOSHER, building a food safety defense line with pharmaceutical-grade standards.

As a technology-driven enterprise, Baida began independently developing popping candy production equipment as early as 2010 and has continuously advanced its manufacturing processes. Today, Baida popping candy leads globally in key performance metrics such as bubble radius, gas content, and heat resistance. The current market version—Baida Popping Candy 3.0—not only withstands an exceptionally wide storage temperature range from -20°C to +52°C and demonstrates enhanced heat resistance up to 52°C, but also delivers a gentler and safer popping sensation that protects the delicate oral mucosa of young children.

In production, Baida enforces rigorous quality control protocols: every batch undergoes a 7-day temperature-resistance test before leaving the factory, microbial testing cycles have been shortened to just 3 days, and moisture content is strictly maintained below 2.5% to ensure consistent stability and taste even under high-temperature conditions. Furthermore, production takes place in a Class-100,000 cleanroom, supported by an automated packaging line capable of producing 800 packs per minute, guaranteeing both hygiene and product uniformity during high-volume manufacturing.

OEM/ODM Model, Empowering Brands with Infinite Possibilities

For brands in Europe and America seeking product differentiation, Baida offers more than just manufacturing; it provides a comprehensive “co-development solution” from concept to realization. Its OEM/ODM services showcase remarkable flexibility and depth:

In terms of product categorization, Baida offers popping candy in four granule sizes: large, medium, small, and standard. Formulations include lactose-based, maltose-based, and sugar-free options to meet diverse health needs. In terms of color, Baida provides a full range of choices from natural to synthetic pigments, ensuring both visual appeal and regulatory compliance.

Regarding taste and flavor, Baida boasts an extensive flavor library covering 48 major series: popular fruits, citrus, berries, bakery flavors, exotic flavors (e.g., chili pickles, mustard), herbal teas, tropical fruits, and complex flavors (such as sea salt lemon, jasmine white grape mint). Whether classic tastes or cutting-edge innovations, Baida offers corresponding solutions.


In terms of packaging formats, Baida offers a diverse range of solutions that span all channels and scenarios. Our offerings not only meet retail requirements—such as triangle sachets, stick packs, and four-side-seal sachets—but also address professional needs across foodservice and industrial applications. Additionally, for food industry clients, we provide large-format bulk packaging in bags or drums. All packaging solutions are fully customizable in size, material, printing, and structural design, empowering brands to achieve a cohesive and distinctive presentation that seamlessly integrates product and packaging identity.

Notably, with highly automated production lines and streamlined collaboration processes, Baida can complete product sampling within seven days, showcasing its ability to quickly respond to market changes and meet clients’ needs for rapid new product launches.

“Popping Candy+”, Initiating a New Era of Creative Delights

In recent years, positioning itself as a “global fun food solutions provider”, Baida has promoted the concept of “everything can be popping candy”, aiming to innovate by combining popping candy with other delights such as ice cream, filled cookies, milk tea, yogurt, probiotics, roast duck, duck necks, coffee, etc., intending to bring the joy of popping to every corner of the world.

During collaborations, Baida actively participates in early-stage market strategies, packaging design, and sales advice, providing one-stop services including “co-development + agile production + quality control assurance + global logistics”. It supports partners comprehensively from product ideation, packaging, marketing materials creation, to market feedback analysis. Based on sales data and consumer feedback, Baida offers profound cultural insights and innovative solutions to help partners navigate market trends with precision.

To date, Baida has over 200 partners globally, with products sold in more than 100 countries and regions, including renowned brands like McDonald’s, Burger King, Oreo, Orion, Gemini Food, Mitsupio, and others. With a service network spanning Southeast Asia, Europe, America, the Middle East, and beyond, Baida has become the largest R&D and manufacturing enterprise for popping candy worldwide.

The release of the “Baida Popping Candy OEM&ODM Strategy Handbook” not only systematically showcases its integrated capabilities but also serves as an invitation to the global market for cooperation. Baida is ready to join hands with partners worldwide, using “Intelligent Manufacturing in China” as the driving force to jointly create a new era of fun foods.

Beijing Review:Understanding Contemporary China Through Primary Sources

By
Advertorial Desk
-

BEIJING, Dec. 12, 2025 /PRNewswire/ — In less than half a century, China has moved from being one of the world’s poorest countries to a technological and economic powerhouse.

China has achieved unprecedented development successes. How do Chinese leaders themselves interpret the country’s development path?

The publication of the fifth volume of Xi Jinping: The Governance of China in July represents a significant milestone in the international dissemination of contemporary Chinese political thought. This book offers a direct window into the governing philosophy that has guided China through a period of profound transformation, global uncertainty and institutional reform.

Chinese modernization is presented as both the historical mission of national rejuvenation and an ongoing process of building a modern socialist country. The narrative underscores that China’s development path is unique in its scale, sequencing and political foundations—yet is deeply connected to global transformations.

This publication functions as an authoritative source for understanding China’s policy decisions, long-term development goals and strategic responses to global shifts. Plus, it provides clarity on how China interprets its contributions to international development, governance reform and global stability.

High-quality economic development strongly focuses on cultivating new quality productive forces, deepening reform and expanding high-standard opening up to the world. These ideas are not abstract formulations; they constitute the intellectual framework guiding China’s efforts to upgrade its industrial structure, strengthen technological innovation and adapt to a more complex global economy. (First introduced in 2023, new quality productive forces represent China’s strategic shift toward a more innovative, technology-driven and sustainable economic model to achieve higher productivity, competitiveness and long-term growth—Ed.)

Equally prominent are discussions of the rule of law, whole-process people’s democracy, cultural revitalization, ecological civilization, and China’s leadership and self-reform. These highlight the integration of governance, culture and institutional design within the broader project of China’s modernization. The volume also devotes considerable attention to China’s global role and the vision of building a community with a shared future for humanity.

Opening up is framed as China’s response to rising protectionism and geopolitical fragmentation. It is associated with high-standard economic cooperation, alignment with UN Sustainable Development Goals and a shared responsibility to safeguard global prosperity. What began as an economic strategy has thus matured into a principle of global governance and an element of China’s international identity.

The same dynamic evolution is visible in discussions of the Belt and Road Initiative (BRI). Across earlier volumes, the BRI, first proposed by Xi in 2013, transitioned from an infrastructure-focused connectivity initiative to a broad platform for international cooperation. This shift reflects China’s intention to position the BRI within the broader architecture of a multipolar world, offering a complement—not a competitor—to existing development models.

Understanding this internal logic is crucial, especially for audiences in Europe and the wider West. China’s rise does not merely reflect economic growth; it signals the emergence of alternative perspectives on development, governance and global order. Engaging with these perspectives is not an act of endorsement but of intellectual responsibility. In an era of global interdependence, misunderstanding China imposes costs not only on bilateral relations but on global problem-solving.

ZIEA Unveils World’s First AI Desktop Calendar Designed to Reclaim Your Focus in an Age of Distraction

By
Advertorial Desk
-

SAN FRANCISCO, Dec. 12, 2025 /PRNewswire/ — ZIEA, an innovator in personal productivity hardware, today announced the upcoming launch of the ZIEA AI Calendar, the world’s first dedicated desktop device designed to help users master their time and disconnect from digital noise. By combining unified calendar syncing with a physical “Focus” interface, ZIEA offers a tangible solution to the modern crisis of smartphone distraction.

In an era where the average person checks their phone 144 times a day, trying to plan a schedule on a smartphone often leads to getting lost in social media. ZIEA solves this by decoupling the calendar from the chaos of the phone, providing a dedicated “Head-Up Display” for life’s most important tasks.

ZIEA, world's 1st AI calendar.
ZIEA, world’s 1st AI calendar.

The Philosophy: Reclaiming Focus from the “Attention Economy”

ZIEA was built on a simple philosophy: To manage your time, you must first protect your attention.

“We realized that the tool we use to plan our lives—the smartphone—is also the tool designed to distract us,” said Dr. Darcy, Co-founder of ZIEA. “We built ZIEA to be a sanctuary for your focus. It allows you to visualize your day and execute your goals without the risk of falling into a digital rabbit hole. It is about moving from being busy to being truly effective.”

The Solution: World’s First AI-Powered Desktop Companion

ZIEA is not just a digital calendar; it is a command center powered by advanced AI. It bridges the gap between intention and action through four core pillars:

  • Unified “Life” View: ZIEA automatically syncs Google, Apple, and Outlook calendars into one dedicated, always-on display. Users can see their entire day at a glance without unlocking a single device.
  • The Physical “Focus” Button: With a single press of a physical button, ZIEA activates a “Deep Work” mode that can silence the user’s paired smartphone and block notifications, creating an instant environment for flow.
  • AI-Powered Planning: Users can use voice commands to instantly log events or ask the AI to break down abstract goals (e.g., “Plan a marathon training schedule”) into actionable calendar blocks. The AI also analyzes workload to suggest wellness breaks.
  • Tangible Satisfaction: Every event features a digital checkbox. Users can physically check off meetings and tasks as they complete them, turning the abstract passage of time into a satisfying list of achievements.

Design Meets Utility Designed for the modern desk, ZIEA also functions as a high-speed 165W charging hub, capable of powering laptops, phones, and accessories, eliminating cable clutter while optimizing workflow.

Availability The ZIEA is currently available for pre-order, with early backers receiving a 40% discount.

To learn more about the device and join the waitlist, visit ziea.net.

About ZIEA ZIEA is a hardware technology company dedicated to building tools that respect human attention. Founded by a team of designers and engineers tired of digital distraction, ZIEA aims to bring tangible focus back to the digital workspace.

Cadonilimab (PD-1/CTLA-4) Receives FDA Clearance for Global Phase III First-Line Gastric Cancer Trial Versus Nivolumab

By
Advertorial Desk
-

HONG KONG, Dec. 12, 2025 /PRNewswire/ — Akeso, Inc. (9926.HK) (“Akeso” or the “Company”) announced FDA approval to initiate COMPASSION-37/AK104-311 trial, a global multicenter Phase III trial in gastric cancer evaluating cadonilimab, a first-in-class PD-1/CTLA-4 bispecific antibody. The study will compare cadonilimab plus chemotherapy against chemotherapy with or without nivolumab as first-line treatment for HER2-negative, unresectable or metastatic gastric/gastroesophageal junction adenocarcinoma.

This is the second international registrational study for cadonilimab, following the ongoing trial in immunotherapy-resistant hepatocellular carcinoma. COMPASSION-37 represents a pivotal advancement in cadonilimab’s global development and a concrete step in Akeso’s worldwide strategy, reinforcing its leadership in next-generation immuno-oncology. The company remains committed to its dual-track approach of proprietary development and strategic collaboration, leveraging global resources to accelerate cadonilimab’s international availability and expand accessible treatment options for patients worldwide.

Chemotherapy with or without PD-1 inhibitors, such as nivolumab, represents the international standard of care for advanced gastric cancer. However, the disease exhibits significant heterogeneity. While PD-1 treatment in combination with chemotherapy remains an effective treatment in many gastric cancer patients with high PD-L1 expression (CPS >5), its efficacy is markedly limited in gastric cancer patients with low PD-L1 expression (CPS <5) or negative PD-L1 expression (CPS <1). These low and negative PD-L1 patients constitute well more than half of the total gastric cancer patient population.

In 2024, the FDA narrowed the indication for all approved PD-1 inhibitors in the first-line treatment of advanced gastric cancer, restricting their use to PD-L1-positive patients. Authoritative guidelines, including those from the National Comprehensive Cancer Network (NCCN) and the European Society for Medical Oncology (ESMO), also prioritize recommending nivolumab-based regimens for patients with PD-L1 CPS ≥5. This underscores that treating advanced gastric cancer in PD-L1 low-expressing and negative patients has become a globally recognized clinical challenge.

In 2024, based on the COMPASSION-15 study results, cadonilimab in combination with chemotherapy was approved in China for the first-line treatment of gastric cancer, demonstrating benefit across all patient populations, including both PD-L1 positive and negative subgroups.

COMPASSION-15 is the only global Phase III clinical study in first-line advanced gastric cancer to have demonstrated survival benefit across all patient populations, irrespective of PD-L1 expression status. In this trial, patients with low PD-L1 expression and those who were PD-L1-negative accounted for as high as 49.8% and 23% of the enrolled population, respectively, significantly exceeding proportions observed in historical studies of its kind. The robust representation of low and negative PD-L1 patients in the study and the effective treatment of these patients validates cadonilimab’s broad-spectrum antitumor efficacy beyond PD-L1 dependency in gastric cancer.

Long-term follow-up data showed that cadonilimab plus chemotherapy significantly reduced the risk of death by 39% in the overall population compared to the control group (OS HR 0.61), regardless of PD-L1 status. In the PD-L1 CPS ≥5 subgroup, the reduction in mortality risk reached 51% (OS HR 0.49). Importantly, even among patients with low PD-L1 expression (CPS <5), a statistically significant 24% reduction in mortality risk was maintained (OS HR 0.76). These results were presented as an oral report at ESMO 2025. Earlier interim analysis data from the COMPASSION-15 study had been released as a prominent oral presentation at AACR 2024, with the full manuscript subsequently published in the Nature Medicine. These results highlight cadonilimab's potential to elevate the current standard of tumor immunotherapy and address clinical challenges unmet by single-target agents.

Forward-Looking Statement of Akeso, Inc.

This announcement by Akeso, Inc. (9926.HK, “Akeso”) contains “forward-looking statements”. These statements reflect the current beliefs and expectations of Akeso’s management and are subject to significant risks and uncertainties. These statements are not intended to form the basis of any investment decision or any decision to purchase securities of Akeso. There can be no assurance that the drug candidate(s) indicated in this announcement or Akeso’s other pipeline candidates will obtain the required regulatory approvals or achieve commercial success. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.

Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and health care legislation in P.R.China, the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; Akeso’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the Akeso’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.

Akeso does not undertake any obligation to publicly revise these forward-looking statements to reflect events or circumstances after the date hereof, except as required by law.

About Akeso

Akeso (HKEX: 9926.HK) is a leading biopharmaceutical company committed to the research, development, manufacturing and commercialization of the world’s first or best-in-class innovative biological medicines. Founded in 2012, the company has created a unique integrated R&D innovation system with the comprehensive end-to-end drug development platform (ACE Platform) and bi-specific antibody drug development technology (Tetrabody) as the core, a GMP-compliant manufacturing system and a commercialization system with an advanced operation mode, and has gradually developed into a globally competitive biopharmaceutical company focused on innovative solutions. With fully integrated multi-functional platform, Akeso is internally working on a robust pipeline of over 50 innovative assets in the fields of cancer, autoimmune disease, inflammation, metabolic disease and other major diseases. Among them, 26 candidates have entered clinical trials (including 15 bispecific/multispecific antibodies and bispecific ADCs. Additionally, 7 new drugs are commercially available. Through efficient and breakthrough R&D innovation, Akeso always integrates superior global resources, develops the first-in-class and best-in-class new drugs, provides affordable therapeutic antibodies for patients worldwide, and continuously creates more commercial and social values to become a global leading biopharmaceutical enterprise.

For more information, please visit https://www.akesobio.com/en/about-us/corporate-profile/ and follow us on Linkedin.

LOTTE Chemical Indonesia, Milliken, and Tederic host joint seminar showcasing advanced polypropylene solutions

By
Advertorial Desk
-

JAKARTA, Indonesia, Dec. 11, 2025 /PRNewswire/ — LOTTE Chemical Indonesia, a major petrochemical company and one of the leading resin producers, joined forces with global additives manufacturer Milliken & Company and machinery partner Tederic to host a joint seminar on November 21, 2025, highlighting the latest innovations in polypropylene production and processing.

Group photos of Joint Seminar
Group photos of Joint Seminar

This collaborative event underscored the commitment of all three companies to driving innovation, sustainability, and operational excellence in plastics manufacturing. Seminar highlights include:

  • LOTTE Chemical Indonesia introduced various polypropylene grades, including J-560S. Enhanced with a Milliken clarifier additive, J-560S delivers exceptional clarity, nucleation capability, and energy savings for high-performance packaging and consumer goods.
  • Milliken shared insights on 2026 market trends and demonstrated how Millad® NX® 8000 additive technology enables faster cycle times, improved moldability, and superior results in polypropylene manufacturing.
  • Tederic showcased its electric Neo series injection molding machines, designed for high productivity and energy efficiency, ensuring reliable performance and quality output when processing advanced polypropylene grades.

“This seminar marks a pivotal moment for LOTTE Chemical Indonesia and our partners,” said Park Woo Jin, Marketing General Manager at LOTTE Chemical Indonesia. “By collaborating with Milliken and Tederic, we are driving innovation and sustainability in the region’s plastics industry.”

The seminar also featured a special UL ceremony recognized downstream customers who have adopted Millad NX 8000, enabling significant energy savings in injection molding production. It follows a recent celebration of LOTTE Chemical Indonesia’s newly established facility, which boasts an annual production capacity of 1 million tons of ethylene, 520,000 tons of propylene, 350,000 tons of polypropylene, 140,000 tons of butadiene, and 400,000 tons of BTX (benzene, toluene, and xylene).

“Innovation thrives through collaboration,” said Daniel Tanzil, country manager for Milliken’s plastic additives business. “Working together with LOTTE Chemical Indonesia and Tederic demonstrates how shared expertise can accelerate progress toward more energy-efficient, high-performing materials.”

To learn more about LOTTE Chemical Indonesia’s portfolio of high-quality resins, visit www.lottechem.id. To learn more about Milliken plastic additives, visit www.milliken.com.

To learn more about Tederic’s injection molding machinery solutions, visit www.tedericglobal.com.

About Milliken

Milliken & Company is a global manufacturing leader whose focus on materials science delivers tomorrow’s breakthroughs today. From industry-leading molecules to sustainable innovations, Milliken creates products that enhance people’s lives and deliver solutions for its customers and communities. Drawing on thousands of patents and a portfolio with applications across the textile, flooring, chemical and healthcare businesses, the company harnesses a shared sense of integrity and excellence to positively impact the world for generations. Discover more about Milliken’s curious minds and inspired solutions at milliken.com and on Facebook, Instagram, and LinkedIn.

About Lotte Chemical Indonesia

PT LOTTE Chemical Indonesia (LCI) is a petrochemical company committed to supporting the growth of Indonesia’s chemical and manufacturing industries as well as global markets. As part of LOTTE Chemical Corporation, LCI established the first naphtha cracker complex in Indonesia in the past three decades. The facility produces ethylene, propylene, mixed-C4, and pyrolysis gasoline using advanced technology. With an annual production capacity of 1 million tons of ethylene, 520,000 tons of propylene, 350,000 tons of polypropylene, and several other chemical products, LCI plays a vital role in strengthening Indonesia’s petrochemical self-sufficiency and meeting global market demand. For more information, please visit www.lottechem.id. 

About Tederic

Tederic is a global injection molding machine manufacturer. As the first injection molding machine company listed on the main board of China, Tederic has the core technology and manufacturing capabilities to provide customers with comprehensive plastic injection molding solutions with technical support in all aspects of your production. Tederic has 6 overseas subsidiaries and 8 service networks in the world. Find more about Tederic and its latest technology at www.tedericglobal.com.

DWMaterials: “Building Trust Through Precise Physical Analysis”

By
Advertorial Desk
-

SEOUL, South Korea, Dec. 12, 2025 /PRNewswire/ — DWMaterials announced that it has successfully developed a stable heat-generation control technology. This advancement enables the company to resolve issues such as reduced magnetic field separation performance and coil damage caused by insulation breakdown in de-ironing equipment.

DWMaterials is a technology-driven company that integrates electromagnetics, mechanical engineering, and physics to solve problems through precise scientific analysis and data-based research.

Its proprietary simulation technologies—grounded in the Biot–Savart law and Maxwell’s equations—enable high-precision modeling of magnetic fields and optimized internal magnetic field design within screening systems, earning DWMaterials recognition as one of the industry’s most advanced technology innovators.

At its R&D center, led by a team of PhD-level researchers, DWMaterials conducts comprehensive modeling across all processes, from magnetic field measurement to thermal distribution analysis. This approach allows the company to achieve both high magnetic power and operational stability, establishing a strong foundation for its reputation as a provider of reliable and scientifically validated solutions.

Moving forward, DWMaterials aims to go beyond its role as a conventional manufacturer to become a trusted technology partner driving quality innovation across domestic and global materials industries.

MIMO: The AI-Native Storage Species Enables Desktop Scale AI Clusters With NVIDIA DGX Spark

By
Advertorial Desk
-

  • Engineered for the AI era, MIMO delivers breakthrough metrics: 400 GB/s bandwidth, 54 million IOPS, and 40–90 μs latency—all within a form factor comparable to a large suitcase.
  • MIMO serves as both a high-performance data hub for large-scale GPU clusters and a flexible edge deployment platform, extending seamlessly to desktop environments where it orchestrates workflows with various DGX Spark units based on NVIDIA’s GB10 Grace Blackwell superchip.
  • This architecture enables independent AI clusters supporting up to 16 computing nodes within constrained environments, managing the complete workflow from large-scale pre-training and fine-tuning to production inference—effectively democratizing enterprise-grade AI capabilities for labs, edge sites, and distributed teams.

SINGAPORE – Media OutReach Newswire – 12 December 2025 – “Maximize input, maximize output, perfect—this is the architectural breakthrough we’ve been waiting for. I never expected to witness it here in the East”. At the recently concluded China Hi-Tech Fair (CHTF), a seasoned AI architect from New York shared this reflection after examining what has been termed a “new species of storage”—the MIMO system at the Ridger booth.


image-1.jpeg

Professor Zhang Sheng from Tsinghua University Shenzhen International Graduate School expressed a more pragmatic view: “With this solution, we finally no longer have to rely on the university’s data center. Our current annual budget alone is enough to deploy an AI cluster within our lab that better fits our needs—this will significantly boost our research efficiency both technically and operationally. It’s truly fantastic news.”

Asia Debut Marks Industry Inflection Point

Earlier at the 8th China International Import Expo (CIIE), the solution’s core—the world’s first AI-native storage system MIMO—made its strategic Asian debut. Engineered for the AI era, MIMO delivers breakthrough metrics: 400 GB/s bandwidth, 54 million IOPS, and 40–90 μs latency—all within a form factor comparable to a large suitcase.

The platform’s defining Fast-Light-Edge proposition, delivered through its breakthrough architecture, cut through the exhibition noise, generating immediate and widespread attention. MIMO earned exclusive features in top-tier media including Hong Kong Ta Kung Pao and China Securities Journal, while its product demonstration videos gained rapid traction across leading digital channels.

Addressing Foundational Challenges: Technical Dialogues That Matter

During the exhibitions, technical leaders from the United States, Spain, Singapore, Colombia, the UAE (Dubai), India, Pakistan, and Hong Kong SAR engaged in substantive dialogues with Ridger’s Asia team, raising questions that revealed systemic industry gaps:

Architectural Transformation & Strategic Positioning
“Can MIMO fundamentally replace legacy storage architectures—traditional NAS, unified, distributed, and parallel file systems—to deliver accelerated parallel training and high-concurrency inference?”
“With such exceptional performance, would deploying MIMO for traditional enterprise applications represent strategic overinvestment or forward-looking infrastructure?”

Mobile Deployment & Borderless Operations
“MIMO’s suitcase-sized footprint suggests unprecedented mobility. Can it truly accompany research teams globally like standard equipment? How does it maintain operational continuity across jurisdictions? What’s the customs protocol for such ‘technical luggage’?”

Seamless Integration & Global Accessibility
“In scenarios with unnetworked AI servers, can MIMO rapidly establish dedicated training environments with true plug-and-play functionality?”
“Does MIMO integrate transparently with existing AI infrastructure and software stacks without requiring modifications?”
“Beyond Asia-Pacific, what’s the procurement pathway for MIMO? Which currencies and payment methods are accommodated?”

Architectural Breakthrough: Redefining What’s Possible

Addressing these operational realities, Ridger demonstrated MIMO’s system-level value—transcending its role as a storage device to become an architectural cornerstone. MIMO serves as both a high-performance data hub for large-scale GPU clusters and a flexible edge deployment platform, extending seamlessly to desktop environments where it orchestrates workflows with various DGX Spark units based on NVIDIA’s GB10 Grace Blackwell superchip.

Notably, eight global OEM partners—including Dell, HPE, Lenovo, xFusion, H3C, MSI, GIGABYTE, and Acer—have concurrently launched Spark versions based on NVIDIA’s GB10 Grace Blackwell superchip, creating a robust compatibility foundation for MIMO’s ecosystem integration.

This architecture enables independent AI clusters supporting up to 16 computing nodes within constrained environments, managing the complete workflow from large-scale pre-training and fine-tuning to production inference—effectively democratizing enterprise-grade AI capabilities for labs, edge sites, and distributed teams.

As Zhu Ting, an industry observer from Beijing, noted: “This represents the ‘IBM PC moment’ for AI infrastructure—transforming specialized capability into accessible utility.”

Market Validation Through Early Adoption

Market response has been decisive. Following the exhibitions, pioneering organizations across pathological image foundation model development, legal-tech innovation, industrial visual inspection, and naked-eye 3D content production have joined Ridger’s Early Access program, validating the architecture’s transformative potential in real-world operational contexts.

Global Rollout: Accelerating Accessibility

Responding to accelerating global demand, Ridger confirmed the imminent launch of the complete MIMO portfolio and optimized solution bundles for specific DGX Spark configurations through the Ridger Official Global Store. Designed as a frictionless procurement channel, the platform will support diverse payment options including multiple fiat currencies and cryptocurrencies—streamlining access to advanced AI infrastructure.

Organizations seeking deeper understanding of MIMO and its integrated lightweight AI solution with DGX Spark are invited to connect with Ridger team or its strategic partner, NVIDIA Elite Solution Partner SinoInfo.
Hashtag: #Technology #ESG #AI #GPU #Enterprise #Finance #Storage #Flash #Compute #DGX-Spark #NVIDIA #AI-Lab #GDS #NAS #AI-Native



The issuer is solely responsible for the content of this announcement.

Ridger

Ridger is a global technology pioneer building next-generation computing & storage infrastructure for the AI era. Born in the East and operating worldwide, Ridger challenges conventional paths to create new technological paradigms.

The team unites seasoned experts from global storage leaders with visionary AI architects, all driven by a shared mission to democratize cutting-edge technology, rejects incremental improvements and hollow prestige, focusing exclusively on foundational breakthroughs that deliver tangible value and sustainable impact.

From architecture to implementation and from service to empowerment, Ridger provides end-to-end solutions that help clients worldwide ascend to their highest summits.

CDNetworks Reinforces Enterprise Reliability: Highlighting Established Commitment to Service Continuity

By
Advertorial Desk
-

SINGAPORE, Dec. 12, 2025 /PRNewswire/ — CDNetworks, the APAC-leading network to deliver edge as a service, is spotlighting its established structured reliability platform, designed to prevent service outages and minimize disruptions for businesses worldwide.

With digital services increasingly dependent on distributed infrastructures, common failure scenarios—such as unsafe configuration changes, inconsistent rollouts, carrier or ISP incidents, and large-scale attacks—continue to challenge businesses. These risks underscore the need for platforms engineered with both resilience and predictable recovery capabilities.

Central to CDNetworks’ commitment to stability is its established three-pillar reliability architecture, which brings structure and operational discipline to how outages are prevented, detected, and contained, covering the full incident lifecycle.

  1. Change Safety
    Disciplined processes ensure safe deployments and minimize risk exposure. Core safeguards include cross-functional reviews, phased grey releases, automated anomaly blocking, and proven rollback plans.
  2. High Availability Architecture
    Existing architecture eliminates single points of failure for continuous service and fast recovery. Its reliability is reinforced by resource redundancy (hardware, bandwidth, and Global Load Balancing) and platform resilience through geo-redundant deployment and automated self-healing agents.
  3. Operational Assurance
    Standardized controls guarantee rapid detection and predictable recovery. This involves regular security scans, end-to-end monitoring, and standardized incident readiness.

“A series of industry-wide outages this year underscored the importance of platform stability and strong recovery capability for digital services,” said Antony Li, Global Head of Infrastructure at CDNetworks. “Our reliability framework ensures customers maintain continuity under pressure, recover quickly from unexpected disruptions, and operate with confidence at global scale.”

As resilience and diversification become central to modern digital strategies, CDNetworks offers a dependable foundation for continuous service delivery, supporting enterprises seeking greater stability and a stronger multi-vendor strategy.

About CDNetworks

As the APAC-leading network with over 2,800 global Points of Presence and more than 20 years of technology experience, CDNetworks delivers the fastest and most secure digital experiences to end users. Our diverse products and services include web performance, media delivery, cloud security, edge computing, zero-trust security, and colocation services — all designed to spur business innovation.

To learn more, visit cdnetworks.com and follow us on LinkedIn.

1...1,7111,7121,713...6,659Page 1,712 of 6,659